🇮🇳IN
Sign In
SH

SHUKRAMED

NSE

Shukra Medtech Limited

₹84.20

+1.98(+2.41%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

SHUKRAMED valuation summary

Shukra Medtech Limited trades at 75.0 times trailing earnings. Return on equity is 28.9% and return on capital employed is 37.0%. The dividend yield is 0.01%. That P/E equals an earnings yield of 1.3%. The median P/E across 101 listed Drug Manufacturers - Specialty & Generic companies is 33.3, so Shukra Medtech Limited trades at a 150% premium to that median.

P/E75.0
ROE28.9%
ROCE37.0%
Dividend yield0.01%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer